Home > Back to Publisher > Report Information

Strategic Analysis of World Sleep Apnea Therapeutic Markets

Frost & Sullivan
March 8, 2004
SKU: MC968850

Abstract Table of Contents Related Reports

Countries covered: Global

Strategic Analysis of World Sleep Apnea Therapeutic Markets

Rest-of-World Markets Hold Growth Potential

With increasing awareness of sleep apnea among the medical fraternity and patients, the demand for therapeutics is expected to grow at a rapid pace, especially in the markets outside North America, Europe, and Japan. The acceptance of auto-setting continuous positive airway pressure (CPAP) devices and high-end masks are expected to drive this growth. The anticipated increase in the number of patients diagnosed and the lowered selling price of therapeutic products such as CPAPs, humidifiers, and masks is likely to result in market expansion in the coming years.

This strategic analysis offers insights into future trends in various product categories of the sleep apnea therapeutics market such as standard, bi-level, high-end, and auto-setting CPAPs, humidifiers, and masks in the global markets. This is likely to help companies align their positioning strategies to benefit from the changing markets and obtain maximum return on investment.

Technology Innovation Enhances Patient Comfort and Expands Market

"Patient compliance is key to the success of a CPAP therapy," says the analyst. "An auto-setting portable CPAP with an integrated humidifier and a patient-friendly mask may lead to optimum patient comfort, resulting in compliance with the therapy."

To attain this, companies marketing sleep apnea therapeutics are channeling more funds into research and development to innovate products that can result in improved patient comfort and compliance. Insurance providers that understand the importance of patient compliance in CPAP therapy are offering coverage. The advent of such patient-friendly CPAP therapy systems is expected not only to increase the number of patients on the therapy, but also result in more patients opting to get diagnosed.

Growing Awareness Drives Penetration of CPAP Therapy

With more than 20 million people suffering from CPAP in the United States alone, the worldwide market potential for CPAP therapy is enormous. However, only a small percentage of patients have been diagnosed and treated. Growing awareness of the gravity of this disorder and the need for CPAP therapy is expected to drive uptake in the coming years. "The study of relationships between cardiac disorders, obesity, and sleep apnea is also expected to encourage patients to seek medical help and subsequently get treated using CPAPs," concludes the analyst.

1 | WORLD SLEEP APNEA THERAPEUTIC MARKETS

  Overview
      1. Introduction

      2. Disclaimer

      3. Certification

      4. Research Scope and Methodology

      5. Market Segmentation

      6. Key Definitions

  Market Dynamics
      1. Industry Challenges

      2. Market Trends

      3. R&D and Technology Trends

  Market Forecasts
      1. Global Sleep Apnea Therapeutic Markets by Geographical Region 2003

      2. Global Market Size 2001-2006

      3. Global Sleep Apnea Therapeutic Markets by Product 2003

      4. Global Sleep Apnea Therapeutic Markets by Region 2001-2006

  Market Forecasts by Product
      1. Global CPAP Markets

      2. Global Masks Markets

      3. Global Humidifiers Markets

  Revenue Analysis
      1. Market Revenue Analysis

      2. Revenue Analysis by Geographical Region

      3. Radar Screen

      4. Customer Priorities

      5. Market Opportunity by Geographical Region

  Growth Strategies
      1. Achieving Sustained Value Growth

      2. Market DNA

      3. Understanding Growth Opportunities

      4. Growth Rates by Geographical Region

      5. What Can be Expected in Future?

  2 | U.S. SLEEP APNEA THERAPEUTIC MARKETS

  Market Forecasts
      1. Introduction

      2. Market Size 2001-2006

      3. Revenue Analysis

  Units and Pricing Forecasts
      1. CPAP Units

      2. Masks Units

      3. Humidifier Units

      4. Pricing Forecasts

  Revenue Forecasts by Product
      1. Market Revenues by Product

      2. CPAP Market Revenues

      3. Masks and Humidifiers Revenues

  Competitive Analysis
      1. Reimbursement Trends

      2. Market Share Analysis

  3 | EUROPEAN SLEEP APNEA THERAPEUTIC MARKETS

  Market Forecasts
      1. Introduction

      2. Market Size 2001-2006

      3. Revenue Analysis

  Units and Pricing Forecasts
      1. CPAP Units

      2. Masks Units

      3. Humidifier Units

      4. Pricing Forecasts

  Revenue Forecasts by Product
      1. Market Revenues by Product

      2. CPAP Market Revenues

      3. Masks and Humidifiers Revenues

  Competitive Analysis
      1. Reimbursement Trends

      2. Market Share Analysis

  4 | JAPANESE SLEEP APNEA THERAPEUTIC MARKETS

  Market Forecasts
      1. Introduction

      2. Market Size 2001-2006

      3. Revenue Analysis

  Units and Pricing Forecasts
      1. CPAP Units

      2. Masks Units

      3. Humidifier Units

      4. Pricing Forecasts

  Revenue Forecasts by Product
      1. Market Revenues by Product

      2. CPAP Market Revenues

      3. Masks and Humidifiers Revenues

  Competitive Analysis
      1. Reimbursement Trends

      2. Market Share Analysis

  5 | REST OF THE WORLD SLEEP APNEA THERAPEUTIC MARKETS

  Market Forecasts
      1. Introduction

      2. Market Size 2001-2006

      3. Revenue Analysis

  Units and Pricing Forecasts
      1. CPAP Units

      2. Masks Units

      3. Humidifier Units

      4. Pricing Forecasts

  Revenue Forecasts by Product
      1. Market Revenues by Product

      2. CPAP Market Revenues

      3. Masks and Humidifiers Revenues

  Competitive Analysis
      1. Market Share Analysis

  6 | COMPETITIVE ANALYSIS

  Competitive Landscape
      1. Introduction

      2. Leading Companies

      3. Global Market Share

      4. Respironics

      5. ResMed

      6. Tyco Healthcare

      7. Weinmann

  Econometrics
      1. Macroeconomic Analysis-I

      2. Macroeconomic Analysis-II

      3. Macroeconomic Analysis-III

      4. Macroeconomic Analysis-IV

  What the Future Holds?
      1. Product Life Cycle Analysis

      2. Already Known to 2010 and Beyond

      3. Competitive Framework

  Frost & Sullivan Awards
      1. Introduction

      2. Product Quality Leadership Award

      3. Technology Leadership Award

      4. Product Line Strategy Award

      5. Product Innovation Award

      6. Product Leadership Award

  7 | FROST & SULLIVAN

  Frost & Sullivan Capabilities
      1. Healthcare Team

      2. Our Capabilities

      3. Key Advantages

      4. Our Consulting Clients

  Growth Consulting
      1. Growth Consulting - Introduction

      2. Growth Consulting Process

      3. Growth Consulting Deliverables

      4. Growth Partnership Service (GPS)

      5. Growth Partnership Services Platform

More Global Respiratory/Pulmonary Reports

Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 by GlobalData
Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H1, 2012 provides data ...

Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 by GlobalData
Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012 provides data on the ...

Lung Injury Global Clinical Trials Review, H1, 2012 by GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury ...

Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 by GlobalData
Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2012 provides data on the Bronchopulmonary Dysplasia ...

Bronchospasm Global Clinical Trials Review, H1, 2012 by GlobalData
Bronchospasm Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2012 provides data on the Bronchospasm clinical trial scenario. ...

See all reports like this >>

Strategic Analysis of World Sleep Apnea Therapeutic Markets

Share this report

Other tasks

Research Assistance

Related Markets

Respiratory/Pulmonary Reports

Free Alert Me service